Antitumor mechanisms when pRb and p53 are genetically inactivated
pRb and p53 are the two major tumor suppressors. Their inactivation is frequent when cancers develop and their reactivation is rationale of most cancer therapeutics. When pRb and p53 are genetically inactivated, cells irreparably lose the antitumor mechanisms afforded by them. Cancer genome studies...
Main Authors: | Zhu, Liang, Lu, Zhonglei, Zhao, Hongling |
---|---|
Format: | Online |
Language: | English |
Published: |
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459916/ |
Similar Items
-
Treating cancer when pRb and p53 cannot be reactivated
by: Zhu, Liang
Published: (2015) -
pRb Inactivation in Mammary Cells Reveals Common Mechanisms for Tumor Initiation and Progression in Divergent Epithelia
by: Simin, Karl, et al.
Published: (2004) -
The In Vivo Role of the RP-Mdm2-p53 Pathway in Signaling Oncogenic Stress Induced by pRb Inactivation and Ras Overexpression
by: Pan, Wenqi, et al.
Published: (2011) -
An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence
by: Rovillain, Emilie, et al.
Published: (2011) -
Prognostic Significance of Immunohistochemical Expression of p53 and Retinoblastoma Gene Protein (pRB) in Curatively Resected Gastric Cancer
by: Song, Hong Suk, et al.
Published: (2005)